Company

Telo Therapeutics, Inc.

Telo Therapeutics researches precision medicines for oncology.

About

Telo Therapeutics researches precision medicines for oncology, focusing on therapies intended to address cancer cell immortality. Founded in California in 2015 by Robert Bell and Joseph Costello, it raised USD 4.20 million in seed funding from Mission BioCapital in June 2021.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in